Arginine Therapy for Sickle Cell Disease Pain

NCT02536170 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease
Vaso-occlusive Pain Episode

Interventions

DRUG: L-arginine
DRUG: L-arginine Loading Dose
OTHER: Placebo

Sponsor

Emory University

Collaborators

[object Object]
[object Object]